# SynapDx Autism Gene Expression Analysis Study (STORY)

> **NCT01810341** · — · COMPLETED · sponsor: **SynapDx** · enrollment: 880 (estimated)

## Conditions studied

- Autism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01810341
- **Lead sponsor:** SynapDx
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2014-07
- **Final completion:** 2014-12
- **Target enrollment:** 880 (ESTIMATED)
- **Last updated:** 2014-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01810341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01810341, "SynapDx Autism Gene Expression Analysis Study (STORY)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01810341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*